A phase II trial of S-1 and concurrent radiotherapy + S-1 chemotherapy for locally advanced pancreatic cancer.
Phase of Trial: Phase II
Latest Information Update: 23 Apr 2016
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 21 May 2012 Planned end date (24 Jun 2012) added as reported by Chinese Clinical Trial Register.
- 02 Aug 2010 New trial record